Home > Insider Trading > Filing (0001209191-20-058367)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Chinook Therapeutics Inc.	KDNY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202785	Eric Dobmeier	C/O Chinook Therapeutics, Inc. 1600 Fairview Ave. E. Seattle WA 98102	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-10	2,000	$13.86	48,337	No	4	P	Direct
Common Stock	Acquisiton	2020-11-11	2,500	$13.75	50,837	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.75 to $14.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.65 to $13.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.